Patents by Inventor Jason Hanko

Jason Hanko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Romidepsin solid forms and uses thereof
    Patent number: 9624271
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: April 18, 2017
    Assignee: Celgene Corporation
    Inventors: Jason Hanko, David Alan Engers, Eric Hagen, Valeriya Smolenskaya, Jeffrey Scott Stults
  • Romidepsin solid forms and uses thereof
    Patent number: 9518094
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Grant
    Filed: February 5, 2015
    Date of Patent: December 13, 2016
    Assignee: Celgene Corporation
    Inventors: Jason Hanko, David Alan Engers, Eric Hagen, Valeriya Smolenskaya, Jeffrey Scott Stults
  • ROMIDEPSIN SOLID FORMS AND USES THEREOF
    Publication number: 20160060300
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Application
    Filed: November 10, 2015
    Publication date: March 3, 2016
    Inventors: Jason HANKO, David Alan ENGERS, Eric HAGEN, Valeriya SMOLENSKAYA, Jeffrey Scott STULTS
  • ROMIDEPSIN SOLID FORMS AND USES THEREOF
    Publication number: 20150218225
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Application
    Filed: February 5, 2015
    Publication date: August 6, 2015
    Inventors: Jason HANKO, David Alan ENGER, Eric HAGEN, Valeriya SMOLENSKAYA, Jeffrey Scott STULTS
  • Romidepsin solid forms and uses thereof
    Patent number: 8980825
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Grant
    Filed: May 19, 2014
    Date of Patent: March 17, 2015
    Assignee: Celgene Corporation
    Inventors: Jason Hanko, David Alan Engers, Eric Hagen, Valeriya Smolenskaya, Jeffrey Scott Stults
  • ROMIDEPSIN SOLID FORMS AND USES THEREOF
    Publication number: 20140336132
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Application
    Filed: July 22, 2014
    Publication date: November 13, 2014
    Inventors: Jason HANKO, David Alan ENGERS, Eric HAGEN, Valelriya SMOLENSKAYA, Jeffrey Scott STULTS
  • ROMIDEPSIN SOLID FORMS AND USES THEREOF
    Publication number: 20140256637
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Application
    Filed: May 19, 2014
    Publication date: September 11, 2014
    Applicant: Celgene Corporation
    Inventors: Jason HANKO, David Alan ENGERS, Eric HAGEN, Valelriya SMOLENSKAYA, Jeffrey Scott STULTS, Vijay Harishchandra NARINGREKAR, Victor PEYKOV, William Rodney FOSS, Neil Lawrence DARLING, Nicholas VROLIJK
  • Crystalline and amorphous forms of nalbuphine hydrochloride
    Patent number: 8536191
    Abstract: The present invention is directed to novel crystalline and amorphous forms of nalbuphine hydrochloride.
    Type: Grant
    Filed: July 21, 2011
    Date of Patent: September 17, 2013
    Assignee: Noramco, Inc.
    Inventors: Jason Hanko, Petinka Vlahova
  • ROMIDEPSIN SOLID FORMS AND USES THEREOF
    Publication number: 20120190817
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Application
    Filed: July 12, 2011
    Publication date: July 26, 2012
    Applicant: Celgene Corporation
    Inventors: Jason Hanko, David Engers, Eric Hagen, Valeriya Smolenskaya, Jeffrey Stults
  • ROMIDEPSIN SOLID FORMS AND USES THEREOF
    Publication number: 20120046442
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Application
    Filed: July 12, 2011
    Publication date: February 23, 2012
    Inventors: Jason Hanko, David Alan Engers, Eric Hagen, Valenya Smolenskaya, Jeffrey Scott Stults
  • CRYSTALLINE AND AMORPHOUS FORMS OF NALBUPHINE HYDROCHLORIDE
    Publication number: 20120029008
    Abstract: The present invention is directed to novel crystalline and amorphous forms of nalbuphine hydrochloride.
    Type: Application
    Filed: July 21, 2011
    Publication date: February 2, 2012
    Inventors: Jason Hanko, Petinka Vlahova
  • CRYSTALLINE FORMS OF ZOTEPINE HYDROCHLORIDE
    Publication number: 20110275695
    Abstract: The invention relates to crystalline forms of zotepine hydrochloride, including the crystalline hydrochloride salt of zotepine and two cocrystals of zotepine hydrochloride with benzoic acid. The preparation and characterization of these crystalline forms of zotepine hydrochloride is described. The invention also relates to the therapeutic use of the crystalline forms of zotepine hydrochloride to treat central nervous system disorders and to pharmaceutical compositions containing them.
    Type: Application
    Filed: June 11, 2009
    Publication date: November 10, 2011
    Applicant: BIONEVIA PHARMACEUTICALS, INC.
    Inventors: Isabel Kalofonos, Dimitris Kalofonos, William Martin-Doyle, Jason Hanko, Eric J. Hagen
  • Crystal form and pharmaceutical compositions of (+)-R-zileuton
    Publication number: 20070244185
    Abstract: Crystalline forms of (+)-R-zileuton, which may be used in pharmaceutical applications, are disclosed. Particular single crystalline forms of (+)-R-zileuton are characterized by a variety of properties and physical measurements. As well, methods of producing crystalline (+)-R-zileuton, and using it to inhibit 5-lipoxygenase activity in subjects to treat a number of diseases, are also discussed.
    Type: Application
    Filed: February 21, 2007
    Publication date: October 18, 2007
    Inventor: Jason Hanko